hepat
e
viru
hev
nonenvelop
positivesens
rna
viru
caus
viral
hepat
human
infect
sever
anim
like
hepat
virus
mainli
replic
liver
caus
acut
selflimit
viral
hepat
hev
fecoor
transmit
caus
larg
waterborn
epidem
variou
part
develop
world
recent
statu
zoonosi
realiz
pig
known
reservoir
viru
zoonot
transmit
hepat
e
occur
due
consumpt
contamin
pork
hev
virion
nm
size
nonenvelop
kb
singlestrand
positivesens
rna
genom
cap
poli
tail
four
genotypesgt
singl
serotyp
geograph
distinct
distribut
gt
found
pig
well
human
genom
encod
three
protein
three
open
read
frame
orf
protein
earli
late
nonstructur
function
respect
encod
amino
acidlong
capsid
protein
selfassembl
viruslik
particl
vlp
express
mammalian
insect
bacteri
cell
like
fecoor
transmit
viru
vlp
exhibit
great
stabil
harsh
environ
gut
variou
properti
vlp
make
attract
tool
develop
oral
deliver
nanoparticl
carri
foreign
epitop
heterolog
dna
small
molecul
properti
outlin
chapter
context
knowledg
viru
larg
outbreak
jaundic
occur
new
delhi
result
contamin
drink
water
raw
sewag
initi
thought
caus
hepat
viru
hav
although
hav
detect
upon
retrospect
test
store
serum
sampl
patient
clinic
sign
symptom
differ
hav
infect
suggest
novel
infecti
agent
respons
outbreak
diseas
first
call
enter
nona
nonb
hepat
etnanbh
dr
mikhail
balayan
studi
outbreak
hepat
among
soviet
troop
afghanistan
voluntari
selfinocul
infect
stool
sampl
develop
clinic
sign
nona
nonb
hepat
monitor
progress
diseas
examin
stool
serum
immun
electron
microscopi
show
presenc
viru
inocul
cynomolgu
macaqu
result
enzymat
histopatholog
confirm
hepat
shed
vlp
fece
antibodi
reactiv
vlp
independ
india
larg
epidem
waterborn
jaundic
concomit
sporad
outbreak
show
characterist
pattern
selflimit
diseas
progress
chronic
affect
young
adult
enter
transmit
high
mortal
pregnant
women
genom
viru
clone
sequenc
upon
isol
bile
experiment
infect
cynomolgu
monkey
follow
identif
sequenc
etiolog
agent
diseas
becam
known
hepat
e
agent
hev
e
may
stand
enter
gut
endem
epidem
featur
adequ
describ
epidemiolog
hev
major
hindranc
studi
hev
replic
cycl
difficulti
cultur
viru
surrog
system
transfect
infecti
genom
replicon
vlp
partial
success
help
understand
hev
biolog
genom
organ
given
fig
three
orf
partial
overlap
encod
three
carri
function
viru
life
cycl
hev
amino
acid
long
nonstructur
earli
viral
protein
respons
variou
step
hev
life
cycl
base
homolog
similar
protein
plussens
rna
virus
propos
posttransl
cleav
four
function
domain
methyltransferas
met
amino
acid
papainlik
cystein
proteas
pcp
amino
acid
rna
helicas
hel
amino
acid
rnadepend
rna
polymeras
rdrp
amino
acid
two
addit
domain
x
macro
poorli
character
express
hev
genom
replicon
variou
system
show
presenc
multipl
smaller
peptid
peptid
react
antimet
hel
rdrp
antibodi
activ
met
hel
rdrp
demonstr
vitro
pcp
x
domain
rna
virus
sar
coronaviru
bind
viral
poli
tail
recruit
poli
adpribos
modifi
cellular
factor
site
replic
late
nonstructur
protein
modul
optim
host
cell
environ
viral
replic
although
delet
interfer
viral
replic
cell
line
prevent
infect
monkey
kda
protein
two
larg
ntermin
hydrophob
domain
amino
acid
amino
acid
two
prolinerich
region
amino
acid
amino
acid
phosphoryl
serin
bind
cytoskelet
element
mapk
phosphatas
via
cysteinerich
domain
domain
substrat
certain
cellular
kinas
domain
two
overlap
pxxp
domain
interact
sever
src
homolog
region
domaincontain
protein
play
two
broad
role
infect
cell
push
cell
toward
prosurviv
phenotyp
attenu
antivir
immun
signal
recent
studi
shown
play
import
role
viru
morphogenesi
egress
inde
statu
nonstructur
protein
also
recent
question
viral
particl
produc
cultur
coat
protein
hostderiv
lipid
viru
shed
fece
hevinfect
patient
associ
lipid
recent
intravir
interactom
creat
yeast
two
hybrid
screen
show
protein
interact
sever
function
unit
protein
probabl
form
dens
connect
hub
interactom
structur
protein
hev
encod
nucleotid
produc
amino
acidlong
polypeptid
form
icosahedr
shell
encapsid
hev
genom
mammalian
cultur
cell
ectop
express
present
two
protein
kda
kda
treat
tunicamycin
endoglysidas
shown
correspond
nonglycosyl
glycosyl
form
respect
glycosyl
nlink
three
conserv
asparagin
residu
asn
capsid
major
determin
host
cell
tropism
mechan
infect
full
length
variou
truncat
version
protein
express
varieti
surrog
express
system
selfassembl
vlp
morpholog
antigen
resembl
viru
baculoviru
system
first
use
express
ntermin
truncat
protein
amino
acid
recombin
protein
kda
produc
along
kda
protein
secret
cultur
medium
form
vlp
nm
express
fulllength
yield
three
protein
kda
kda
kda
correspond
amino
acid
respect
critic
vlpform
region
amino
acid
truncat
form
protein
secret
vlp
insect
cell
interestingli
amino
acid
truncat
vlp
releas
cultur
medium
cell
form
inclus
bodi
cytoplasm
indic
requir
posttransl
modif
assembl
particl
although
clear
whether
assembl
take
place
cell
secret
icosahedr
viral
structur
two
threeand
fivefold
axe
symmetri
dimer
trimer
pentamer
interact
around
two
threeand
fivefold
icosahedr
axe
lead
assembl
vlp
broad
depress
locat
around
fivefold
axi
hev
featur
typic
secret
protein
ntermin
signal
sequenc
conserv
glycosyl
site
interestingli
ntermin
amino
acid
show
maximum
sequenc
diverg
among
hev
genotyp
express
full
length
insect
cell
usual
result
proteolyt
cleav
region
virion
symmetri
monom
truncat
amino
acid
fold
particl
subunit
protrud
spike
first
studi
describ
structur
insect
cellexpress
vlp
cryoem
resolut
sixti
monomer
unit
cluster
dimer
form
lattic
surfac
protrus
spheric
ring
structur
hollow
solvent
easi
access
center
particl
subsequ
xray
crystal
structur
recombin
vlp
express
amino
acid
protein
follow
amino
acid
made
avail
resolut
use
previou
cryoem
map
initi
phase
xray
data
express
insect
cell
amino
acid
yield
vlp
consider
larger
vlp
diamet
inner
stem
measur
reveal
particl
compos
subunit
thu
resembl
nativ
virion
form
particl
protrud
spike
xray
photoelectron
spectroscopi
found
signal
phosphor
larg
vlp
indic
presenc
nucleic
acid
corrobor
detect
kb
rna
particl
three
linear
domain
form
distinct
structur
element
continu
capsid
shell
threefold
protrus
p
twofold
spike
domain
amino
acid
adopt
jellyrol
fold
commonli
observ
small
rna
virus
amino
acid
p
domain
amino
acid
adopt
fold
p
domain
contain
bind
site
neutral
antibodi
receptor
nineteen
diverg
amino
acid
exist
p
domain
across
four
hev
genotyp
nine
surfac
expos
one
fall
antibodybind
region
result
singl
hev
serotyp
bind
sugar
capsid
protein
interfac
may
lead
capsid
disassembl
facilit
cell
entri
capsid
structur
dock
well
particl
addit
n
domain
particl
correspond
ntermin
amino
acid
subunit
vlp
group
three
uniqu
monom
b
c
base
uniqu
geometr
environ
b
subunit
dimer
bent
conform
around
fivefold
axi
c
monom
dimer
flat
conform
twofold
axi
differ
cc
dimer
p
domain
particl
compar
ab
dimer
dimer
hevlpt
variou
monoclon
antibodi
fragment
fuse
b
cell
tag
c
terminu
capsid
protein
character
structur
reveal
major
antigen
site
vlp
surfac
one
major
epitop
hev
protrus
domain
spatial
map
conform
correspond
amino
acid
fig
studi
also
critic
point
abil
foreign
epitop
insert
c
terminu
protein
clone
rather
random
site
insert
c
terminu
allow
proper
quaternari
structur
vlp
form
well
express
foreign
epitop
correct
conform
shorter
construct
protein
also
express
e
coli
seen
selfassembl
higherord
structur
amino
acid
fold
globular
protein
aggreg
averag
size
nm
amino
acid
amino
acid
construct
form
mainli
hexam
partial
denatur
condit
protein
exist
dimer
mimic
domin
antigen
determin
neutral
site
hev
aggreg
purifi
e
coli
proven
efficaci
prevent
vaccin
hev
hepat
e
shown
bind
penetr
cell
line
suscept
hev
infect
domain
amino
acid
form
minimum
region
induc
neutral
antibodi
thu
make
crucial
target
hev
immunolog
recent
zhao
et
al
creat
toolbox
neutral
antibodi
cover
conform
epitop
major
protect
antibodi
produc
found
epitop
region
base
genom
similar
positivesens
rna
virus
hev
propos
replic
cytoplasm
via
negativesens
intermedi
schemat
represent
provid
fig
better
understand
hev
life
cycl
enabl
us
fulli
appreci
potenti
viru
use
model
vlpbase
vaccin
drug
deliveri
system
hepatoma
cell
line
colorect
carcinoma
cell
line
gener
consid
permiss
hev
replic
interestingli
lung
carcinoma
cell
line
also
support
replic
viru
specif
receptor
hev
identifi
although
heparin
sulfat
proteoglycan
hspg
cell
surfac
syndecan
shown
act
nonspecif
attach
factor
account
fecoor
transmit
viru
expect
interact
transgress
oral
stomach
gut
mucosa
reach
hepat
site
via
blood
circul
interest
nonenvelop
rna
viru
show
high
stabil
extrem
ph
bile
blood
undergo
specif
receptor
engag
entri
replic
liver
cell
recent
holla
et
al
shown
hev
entri
liver
cell
line
depend
clathrin
membran
cholesterol
studi
uptak
fitclabel
vlp
cell
treat
variou
small
molecul
inhibitor
sirnamedi
knockdown
transfect
domin
negativeconstitut
activ
construct
shown
vlp
goe
posit
earli
endosom
soon
enter
cell
previous
kapur
et
al
use
gfplabel
vlp
show
entri
depend
clathrin
membran
cholesterol
rna
virus
intern
via
endocytosi
need
releas
cytosol
traffick
site
replic
depend
sever
viral
cytoskelet
compon
endosom
acidif
trigger
uncoat
viral
capsid
mani
virus
although
nt
seem
case
hev
entri
liver
cell
understand
context
hev
enter
transmit
thu
acid
stabl
mechan
uncoat
target
site
replic
escap
earli
endosom
mayb
independ
endosom
acidif
may
occur
endosom
compart
becom
acid
escap
matur
late
endosom
may
involv
lysi
endosom
compart
may
involv
lysi
final
virion
rna
cargo
dna
releas
dna
cargo
may
transport
nucleu
express
still
understood
although
inhibitor
tubulin
actin
polymer
arrest
uptak
reduc
hev
infect
viral
rna
releas
cytoplasm
rapidli
translat
yield
polyprotein
cleav
smaller
function
unit
rdrp
initi
replic
genom
rna
negativesens
intermedi
negativesens
intermedi
templat
synthesi
fulllength
genom
plussens
rna
packag
progeni
virion
plussens
subgenom
rna
translat
structur
nonstructur
late
protein
protein
fulllength
genom
rna
infecti
cell
vivo
anim
impli
subgenom
rna
packag
vision
requir
initi
replic
rna
virus
assembl
intern
membran
sometim
modifi
composit
morpholog
viral
protein
selfassembl
hev
capsid
protein
vlp
well
studi
mammalian
insect
bacteri
system
xing
et
al
show
hev
vlp
abl
encapsid
subgenom
hev
rna
smaller
particl
indic
role
genom
rna
assembl
viru
potenti
packag
signal
identifi
use
yeast
threehybrid
approach
toward
end
genom
within
gene
implic
transloc
clear
although
may
role
viru
assembl
much
known
virion
particl
releas
cell
although
recent
studi
replicontransfect
cell
show
egress
viral
particl
associ
hostderiv
lipid
membran
late
protein
lipid
membran
deriv
cell
surfac
retain
marker
like
transgolgi
network
protein
shown
play
critic
role
egress
interestingli
viru
shed
fece
infect
anim
lack
associ
lipid
indic
probabl
shed
viru
travers
gut
expos
bile
salt
mammalian
immun
system
evolv
elicit
strong
specif
protect
respons
virus
part
due
viral
capsid
structur
allow
multipl
repeat
epitop
express
viral
surfac
addit
virus
larg
enough
engulf
dendrit
cell
dc
first
respond
surveil
system
connect
innat
adapt
branch
immun
classic
infecti
virion
attenu
make
replic
incompet
administ
vaccin
mani
exampl
success
live
attenu
vaccin
oral
polio
vaccin
opv
exampl
highli
effect
erad
polio
part
world
sinc
polioviru
transmit
fecoor
vaccin
person
abl
evad
infect
due
high
level
secret
iga
antibodi
prevent
viru
cross
intestin
barrier
blood
major
concern
vaccin
howev
risk
revers
wildtyp
replicationcompet
viru
concern
like
integr
viral
genom
host
genom
consequ
disrupt
host
gene
cell
life
cycl
larg
overcom
use
vlp
nativ
configur
viral
capsid
andor
envelop
protein
maintain
express
use
yeast
bacteri
insect
mammalian
express
system
selfassembl
viral
structur
protein
display
immunolog
epitop
way
would
resembl
proper
conform
virus
without
risk
infect
void
viral
nucleic
acid
complet
replic
vlpbase
vaccin
formul
uniqu
modifi
chang
epitop
expos
surfac
thu
use
platform
present
immunogen
heterolog
sourc
pathogen
sever
vlpbase
vaccin
clinic
trial
alreadi
commerci
avail
tabl
sever
recent
advanc
develop
mucos
deliver
vaccin
formul
mani
use
variou
natur
synthet
polym
sever
make
use
vlp
base
natur
pathogen
virus
among
vlp
base
nanocarri
system
hev
vlp
express
insect
cell
sever
uniqu
structur
properti
make
particularli
well
suit
oral
administ
nonhuman
primat
hev
vlp
found
protect
challeng
studi
infecti
viru
fig
excit
implic
term
oral
bioavail
immun
potenti
vlp
gener
protect
respons
mammalian
system
variou
structur
properti
vlp
make
amen
modif
provid
excit
platform
develop
mucos
vaccin
threedomain
tertiari
structur
domainss
pcarri
function
independ
other
upon
multimer
domain
form
icosahedr
base
threefold
plateau
p
domain
respons
antigen
dimer
hostcel
interact
fig
domain
connect
p
domain
structur
modular
allow
particl
disassembl
reassembl
vitro
without
chang
capsid
morpholog
ensur
reassembl
independ
requir
dna
rna
strand
encapsul
thu
impli
particl
antigen
properti
howev
import
advantag
structur
modular
hev
capsid
p
domain
extens
modifi
genet
engin
chemic
crosslink
without
affect
selfassembl
stabil
vlp
chimer
vlp
express
peptid
loop
hiv
near
c
terminu
hev
peptid
selfassembl
vlp
fig
express
correctli
surfac
protrus
peptid
induc
cytotox
lymphocyt
respons
ctl
specif
differ
icosahedr
shell
chimer
wildtyp
vlp
although
orient
p
domain
slightli
thicker
rotat
fig
cryoem
densiti
map
fit
well
crystal
structur
hev
vlp
fig
inject
oral
mice
induc
strong
specif
immun
respons
fig
igg
secretori
iga
antibodi
elicit
along
cellmedi
immun
respons
interestingli
administr
made
without
need
extern
adjuv
major
limit
nonrepl
oral
deliveri
system
cross
gut
epitheli
barrier
chemic
modif
reengin
hev
vlp
made
express
cellspecif
target
ligand
lab
current
tri
develop
one
ligand
would
allow
chimer
hev
vlp
zone
immun
cell
gut
mucos
system
therebi
increas
rapid
access
vlp
b
immun
cell
nearest
lymphoid
organ
hevvlp
owe
resembl
fecoor
transmit
viru
show
high
stabil
resist
proteolyt
enzym
solventexpos
part
protrus
domain
contain
featur
make
suscept
trypsin
cleavag
howev
chimer
p
domain
argininerich
peptid
increas
suscept
action
intestin
proteas
could
major
pitfal
context
use
vlp
nanocarri
vaccin
interestingli
found
vlp
remain
intact
treat
trypsin
pepsin
observ
electron
microscopi
fig
proteolyt
cleavag
take
place
like
end
c
termin
end
insert
evidenc
kda
band
circl
triangl
hevspecif
antibodi
respons
depict
circl
tagspecif
respons
shown
triangl
background
antibodi
level
hev
tag
nonimmun
mice
shown
squar
cross
respect
sera
sampl
dilut
fecal
suspens
mgml
dilut
specif
antihev
respons
measur
enzymelink
immunosorb
assay
elisa
use
synthes
peptid
antigen
b
cellmedi
immun
term
specif
cell
lysi
cytotox
lymphocyt
three
immun
organ
measur
mice
oral
treat
close
circl
control
mice
open
circl
control
synthet
peptid
use
c
antibodi
isotyp
titer
iga
igm
igg
subclass
tag
hev
measur
intestin
fluid
oral
immun
mice
use
isotypespecif
secondari
antibodi
shown
endpoint
titer
solid
open
bar
indic
antibodi
level
mous
immun
chimer
vlp
vlp
without
tag
epitop
insert
respect
observ
trypsin
treatment
sdspage
reactiv
hiv
antibodi
fig
trypsin
treatment
caus
surfac
spike
dissoci
form
vlp
due
hydrophob
interact
hold
quaternari
structur
vlp
togeth
also
stabil
dimer
interact
two
p
domain
spike
even
trypsin
cleavag
hydrophob
residu
beta
strand
p
domain
form
strong
interact
c
termin
region
therebi
maintain
integr
vlp
structur
fig
sequenc
divers
seen
amino
acid
p
domain
across
genotyp
nine
residu
access
capsid
surfac
intriguingli
one
diverg
amino
acid
lie
within
antibodi
bind
region
despit
four
genotyp
hev
present
singl
serotyp
major
consider
proteinbas
oral
deliveri
system
protein
elicit
immun
respons
therebi
make
nanocarri
unreus
seen
modif
genet
engin
within
p
domain
hev
vlp
done
without
effect
particl
format
hev
vlp
antigen
lie
exclus
p
domain
therefor
conform
epitop
bind
monoclon
antibodi
made
three
loop
around
insert
foreign
epitop
residu
disrupt
conform
epitop
bound
without
alter
vlp
properti
antigen
foreign
epitop
fig
b
elimin
issu
selfimmun
aris
mani
mucos
vlp
system
polyoma
viru
hollow
core
vlp
util
carri
foreign
dna
critic
posit
charg
residu
inner
surfac
vlp
allow
encapsul
neg
charg
nonsequencespecif
dna
incorpor
achiev
hev
vlp
dimer
present
solid
surfac
color
gray
violet
light
magenta
p
domain
domain
domain
respect
residu
along
fab
bind
interfac
color
accord
element
green
carbon
blue
nitrogen
red
oxygen
cryoem
densiti
map
fit
crystal
structur
view
along
bound
fab
molecul
neighbor
dimer
drawn
ribbon
mode
color
wheat
top
rightsid
view
dimer
fit
cryoem
densiti
map
bottom
lefta
dimer
view
along
twofold
axi
overlap
cryoem
densiti
map
bottom
righttop
view
dimer
view
along
twofold
axi
amino
acid
respons
bind
label
b
chimer
hev
vlp
abrog
hev
antibodi
bind
elisabas
determin
reactiv
antibodi
white
bar
black
bar
nonstriat
wtvlp
striat
data
repres
triplic
experi
express
mean
standard
deviat
disassembl
particl
dimer
use
dtt
egta
subsequ
allow
reassembl
presenc
dna
calciumrich
environ
thu
hev
vlp
potenti
exploit
carrier
oral
deliver
dna
vaccin
encapsul
gag
dna
plasmid
hev
vlp
oral
administ
mice
strong
specif
humor
well
cellmedi
immun
respons
gener
local
system
lymphoid
organ
fig
b
indic
oral
dna
vaccin
success
deliv
lymphoid
organ
also
allow
particl
enter
immun
cell
undergo
uncoat
releas
encapsul
dna
gag
gene
express
took
place
success
gag
protein
present
success
foreign
antigen
seen
antigag
figur
humor
immun
mice
oral
inocul
gag
dnaencapsul
chimer
hev
vlp
circl
triangl
repres
immun
respons
gag
protein
vlp
nake
dna
vaccin
respect
b
cellmedi
immun
term
specif
cell
lysi
cytotox
lymphocyt
respons
three
immun
organ
measur
mice
oral
treat
gag
dnaload
close
circl
control
mice
open
circl
control
nake
gag
dna
vaccin
use
c
immunogold
label
antigag
antibodi
gut
epitheli
section
mice
oral
immun
gag
dnaencapsul
vlp
immunegold
label
electron
micrograph
gut
epitheli
section
oral
immun
mice
fig
insect
cell
culturebas
protein
express
system
inexpens
easi
scale
eukaryot
insect
cell
allow
correct
fold
posttransl
modif
purifi
protein
use
therapeut
high
degre
puriti
achiev
easi
purif
process
particularli
recombin
protein
secret
cell
cultur
medium
hev
capsid
protein
express
spodoptera
frugiperda
trichoplusia
ni
insect
cell
selfassembl
vlp
secret
cultur
medium
natur
human
pathogen
virus
evolv
capsid
protein
recogn
immun
system
intern
antigenpres
cell
apc
process
present
context
major
histocompat
mhc
molecul
viral
antigen
expos
lymphocyt
gener
primari
memori
respons
featur
allow
chimer
hev
vlpbase
vaccin
administ
without
need
extern
adjuv
enhanc
immun
respons
artifici
adjuv
alum
variou
side
effect
relat
irregular
transloc
nonspecif
site
unsuit
use
specif
vaccin
antigen
requir
respons
vlp
hand
easili
encount
innat
immun
system
turn
prime
adapt
immun
system
gener
specif
strong
respons
chimer
antigen
dna
vaccin
thu
chimer
hev
vlp
uniqu
posit
term
abil
express
correctli
fold
foreign
antigen
also
carri
heterolog
dna
use
dna
vaccin
summar
fig
order
fulli
capit
use
hev
vlp
drug
deliveri
systemvaccin
candid
import
understand
exact
way
perceiv
taken
host
cell
specif
tropism
play
role
specif
target
figur
hev
vlp
chimer
epitop
fold
correctli
express
epitop
surfac
also
incorpor
dna
vaccin
within
core
sinc
first
site
entri
vlp
would
oralbucc
gut
mucosa
critic
studi
receptor
present
cell
gut
immun
facilit
hev
vlp
entri
expos
dc
vlp
would
expect
taken
may
util
differ
set
cell
surfac
molecul
bind
engulf
although
receptor
hev
known
bind
heparan
sulfat
proteoglycan
hspg
hepatocyt
cell
surfac
crucial
understand
nanocarri
enter
cell
deliv
cargo
mani
cytoplasm
replic
rna
virus
enter
cell
endocytosi
releas
endosom
system
cytosplasm
travel
site
replic
exploit
cytoskelet
system
liver
cell
hev
enter
via
endocytosi
earli
endosom
use
clathrin
membran
cholesterol
microtubular
network
facilit
success
infect
escap
endosom
trigger
lower
endosom
ph
explor
mechan
endosom
escap
carri
particularli
relev
context
hev
vlp
dna
deliveri
ultim
goal
use
oral
activ
vlp
gene
therapi
proofofconcept
alreadi
seen
hev
vlp
carri
dna
vaccin
success
gain
exposur
access
immun
system
subsequ
gener
immun
respons
hev
vlp
uniqu
posit
among
vlpbase
oral
deliv
nanocarri
despit
nonrepl
proteinbas
particl
structur
featur
make
ideal
suit
mani
avail
system
